145 related articles for article (PubMed ID: 27798894)
1. KRAS Mutant Status, p16 and β-catenin Expression May Predict Local Recurrence in Patients Who Underwent Transanal Endoscopic Microsurgery (TEMS) for Stage I Rectal Cancer.
Sideris M; Moorhead J; Diaz-Cano S; Bjarnason I; Haji A; Papagrigoriadis S
Anticancer Res; 2016 Oct; 36(10):5315-5324. PubMed ID: 27798894
[TBL] [Abstract][Full Text] [Related]
2.
Sideris M; Moorhead J; Diaz-Cano S; Haji A; Papagrigoriadis S
Anticancer Res; 2017 Mar; 37(3):1349-1357. PubMed ID: 28314302
[TBL] [Abstract][Full Text] [Related]
3. KRAS mutations and CDKN2A promoter methylation show an interactive adverse effect on survival and predict recurrence of rectal cancer.
Kohonen-Corish MR; Tseung J; Chan C; Currey N; Dent OF; Clarke S; Bokey L; Chapuis PH
Int J Cancer; 2014 Jun; 134(12):2820-8. PubMed ID: 24259266
[TBL] [Abstract][Full Text] [Related]
4. Impact of KRAS, BRAF and PI3KCA mutations in rectal carcinomas treated with neoadjuvant radiochemotherapy and surgery.
Derbel O; Wang Q; Desseigne F; Rivoire M; Meeus P; Peyrat P; Stella M; Martel-Lafay I; Lemaistre AI; de La Fouchardière C
BMC Cancer; 2013 Apr; 13():200. PubMed ID: 23617638
[TBL] [Abstract][Full Text] [Related]
5. Treatment of recurrence after transanal endoscopic microsurgery (TEM) for T1 rectal cancer.
Doornebosch PG; Ferenschild FT; de Wilt JH; Dawson I; Tetteroo GW; de Graaf EJ
Dis Colon Rectum; 2010 Sep; 53(9):1234-9. PubMed ID: 20706065
[TBL] [Abstract][Full Text] [Related]
6. Transanal Endoscopic Microsurgery for Early Rectal Cancer: A Single-Center Experience.
O'Neill CH; Platz J; Moore JS; Callas PW; Cataldo PA
Dis Colon Rectum; 2017 Feb; 60(2):152-160. PubMed ID: 28059911
[TBL] [Abstract][Full Text] [Related]
7. Transanal endoscopic microsurgery versus conventional transanal excision for patients with early rectal cancer.
Christoforidis D; Cho HM; Dixon MR; Mellgren AF; Madoff RD; Finne CO
Ann Surg; 2009 May; 249(5):776-82. PubMed ID: 19387326
[TBL] [Abstract][Full Text] [Related]
8. KRAS mutation status concordance between the primary tumor and the corresponding metastasis in patients with rectal cancer.
Jo P; Bernhardt M; Nietert M; König A; Azizian A; Schirmer MA; Grade M; Kitz J; Reuter-Jessen K; Ghadimi M; Ströbel P; Schildhaus HU; Gaedcke J
PLoS One; 2020; 15(10):e0239806. PubMed ID: 33002027
[TBL] [Abstract][Full Text] [Related]
9. National Early Rectal Cancer Treatment Revisited.
Stornes T; Wibe A; Nesbakken A; Myklebust TÅ; Endreseth BH
Dis Colon Rectum; 2016 Jul; 59(7):623-9. PubMed ID: 27270514
[TBL] [Abstract][Full Text] [Related]
10. Genetic alteration and immunohistochemical staining patterns of ovarian high-grade serous adenocarcinoma with special emphasis on p53 immnnostaining pattern.
Lee SH; Kim H; Kim WY; Han HS; Lim SD; Kim WS; Kim S; Hwang TS
Pathol Int; 2013 May; 63(5):252-9. PubMed ID: 23714252
[TBL] [Abstract][Full Text] [Related]
11. Transanal endoscopic microsurgery for residual rectal cancer (ypT0-2) following neoadjuvant chemoradiation therapy: another word of caution.
Perez RO; Habr-Gama A; Lynn PB; São Julião GP; Bianchi R; Proscurshim I; Gama-Rodrigues J
Dis Colon Rectum; 2013 Jan; 56(1):6-13. PubMed ID: 23222274
[TBL] [Abstract][Full Text] [Related]
12. Management and outcome of local recurrence following transanal endoscopic microsurgery for rectal cancer.
Stipa F; Giaccaglia V; Burza A
Dis Colon Rectum; 2012 Mar; 55(3):262-9. PubMed ID: 22469792
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Value of BRAF and KRAS Mutations in MSI and MSS Stage III Colon Cancer.
Taieb J; Le Malicot K; Shi Q; Penault-Llorca F; Bouché O; Tabernero J; Mini E; Goldberg RM; Folprecht G; Luc Van Laethem J; Sargent DJ; Alberts SR; Emile JF; Laurent Puig P; Sinicrope FA
J Natl Cancer Inst; 2017 May; 109(5):. PubMed ID: 28040692
[TBL] [Abstract][Full Text] [Related]
14. Relationships among
Wan XB; Wang AQ; Cao J; Dong ZC; Li N; Yang S; Sun MM; Li Z; Luo SX
World J Gastroenterol; 2019 Feb; 25(7):808-823. PubMed ID: 30809081
[TBL] [Abstract][Full Text] [Related]
15. Multicentre study of short-course radiotherapy and transanal endoscopic microsurgery for early rectal cancer.
Smart CJ; Korsgen S; Hill J; Speake D; Levy B; Steward M; Geh JI; Robinson J; Sebag-Montefiore D; Bach SP
Br J Surg; 2016 Jul; 103(8):1069-75. PubMed ID: 27146472
[TBL] [Abstract][Full Text] [Related]
16. Oncological Outcomes of Transanal Endoscopic Microsurgery Plus Adjuvant Chemoradiotherapy for Patients with High-Risk T1 and T2 Rectal Cancer.
Xu K; Liu Y; Yu P; Shang W; Zhang Y; Jiao M; Cui Z; Xia L; Chen J
J Laparoendosc Adv Surg Tech A; 2021 Sep; 31(9):1006-1013. PubMed ID: 33026943
[No Abstract] [Full Text] [Related]
17. HER2 status in patients with residual rectal cancer after preoperative chemoradiotherapy: the relationship with molecular results and clinicopathologic features.
Park JS; Yoon G; Kim HJ; Park SY; Choi GS; Kang MK; Kim JG; Jang JS; Seo AN
Virchows Arch; 2018 Oct; 473(4):413-423. PubMed ID: 30056472
[TBL] [Abstract][Full Text] [Related]
18. Characterization of rectal, proximal and distal colon cancers based on clinicopathological, molecular and protein profiles.
Minoo P; Zlobec I; Peterson M; Terracciano L; Lugli A
Int J Oncol; 2010 Sep; 37(3):707-18. PubMed ID: 20664940
[TBL] [Abstract][Full Text] [Related]
19. KRAS and BRAF mutations and PTEN expression do not predict efficacy of cetuximab-based chemoradiotherapy in locally advanced rectal cancer.
Erben P; Ströbel P; Horisberger K; Popa J; Bohn B; Hanfstein B; Kähler G; Kienle P; Post S; Wenz F; Hochhaus A; Hofheinz RD
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1032-8. PubMed ID: 20947270
[TBL] [Abstract][Full Text] [Related]
20. MRI surveillance for the detection of local recurrence in rectal cancer after transanal endoscopic microsurgery.
Hupkens BJP; Maas M; Martens MH; Deserno WMLLG; Leijtens JWA; Nelemans PJ; Bakers FCH; Lambregts DMJ; Beets GL; Beets-Tan RGH
Eur Radiol; 2017 Dec; 27(12):4960-4969. PubMed ID: 28667480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
